Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

Renata M. Martin(Stanford University), Kyle M. Loh(California Institute for Regenerative Medicine)

Nature Communications

June 1, 2020

10.1038/s41467-020-16455-7

Cited by 109

Related Papers

An atlas of transcriptional, chromatin accessibility, and surface marker changes in human mesoderm development

|Scientific Data|2016|84

Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra viruses

|Cell|2022|84

Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

|Developmental Cell|2024|45

Chimpanzee and pig-tailed macaque iPSCs: Improved culture and generation of primate cross-species embryos

|Cell Reports|2022|17

Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells

|Gene Therapy|2020|13